People: The Female Health Company (FHCO.O)

FHCO.O on Consolidated Issue listed on NASDAQ Capital Market

5.52USD
9 Feb 2010
Price Change (% chg)

$0.02 (+0.36%)
Prev Close
$5.50
Open
$5.53
Day's High
$5.53
Day's Low
$5.39
Volume
69,479
Avg. Vol
109,260
52-wk High
$7.79
52-wk Low
$2.81

view people for:

Leeper, Mary 

Brief Biography

Dr. Mary Ann Leeper, Ph.D. is Senior Strategic Adviser, Director of The Female Health Company. Dr. Leeper has served as Senior Strategic Adviser since May 2006. Dr. Leeper served as the President and Chief Operating Officer of the Company from February 1996 to April 2006, as President and Chief Executive Officer of The Female Health Company Division from May 1994 until January 1996, as Senior Vice President - Development of the Company from 1989 until January 1996 and as a Director of the Company since 1987. Dr. Leeper is a shareholder and has served as a Vice President and Director of Phoenix of Illinois since 1987. From 1981 until 1986, Dr. Leeper served as Vice President - Market Development for Searle's Pharmaceutical Group and in various Searle research and development management positions. As Vice President - Market Development, Dr. Leeper was responsible for worldwide licensing and acquisition, marketing and market research. In earlier positions, she was responsible for preparation of new drug applications and was a liaison with the FDA. Dr. Leeper serves on the Board of Neenah Paper, Inc. and is chair of its nominating and governance committee. She is also an adjunct professor at the University of Virginia Darden School of Business.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
204,167 -- -- 255,167

Options Compensation

  Quantity Market Value
Excercisable 790,000 --
Unexercisable 153,612 39,940.00
Excercised -- --
Name Fiscal Year Total
Parrish, O. 765,001
Felch, Donna 419,203
Pope, Michael 416,119
Lee, Janet --
Gargiulo, William 113,542
Leeper, Mary 255,167
As Of 29 Sep 2009
view people for: